ATP III Metabolic Syndrome Diagnostic Criteria
The ATP III criteria require the presence of 3 or more of the following 5 factors: abdominal obesity (waist circumference ≥102 cm in men, ≥88 cm in women), elevated triglycerides (≥150 mg/dL), reduced HDL cholesterol (<40 mg/dL in men, <50 mg/dL in women), elevated blood pressure (≥130/85 mmHg), and elevated fasting glucose (≥100 mg/dL). 1
Core Diagnostic Framework
The National Cholesterol Education Program Adult Treatment Panel III (ATP III) established in 2001 a straightforward diagnostic approach that does not require demonstration of insulin resistance per se, unlike the earlier WHO criteria. 1
The Five ATP III Components
Abdominal Obesity:
- Men: waist circumference ≥102 cm (approximately 40 inches)
- Women: waist circumference ≥88 cm (approximately 35 inches)
- This measurement is highly correlated with insulin resistance 1
Elevated Triglycerides:
- ≥150 mg/dL (1.7 mmol/L)
- Drug treatment for elevated triglycerides counts as meeting this criterion 1
Reduced HDL Cholesterol:
- Men: <40 mg/dL (1.0 mmol/L)
- Women: <50 mg/dL (1.3 mmol/L)
- Drug treatment for reduced HDL cholesterol counts as meeting this criterion 1
Elevated Blood Pressure:
- Systolic ≥130 mmHg and/or diastolic ≥85 mmHg
- Antihypertensive drug treatment in a patient with a history of hypertension counts as meeting this criterion 1
Elevated Fasting Glucose:
- ≥100 mg/dL (includes impaired fasting glucose or type 2 diabetes mellitus)
- Drug treatment of elevated glucose counts as meeting this criterion 1
Key Distinguishing Features of ATP III
No single factor is mandatory for diagnosis—this differs from the IDF criteria which later made abdominal obesity a required component. 1 The ATP III approach is more flexible and does not prioritize one risk factor over others.
No requirement for insulin resistance testing, making it more practical for clinical use compared to WHO criteria that required direct measurement of insulin resistance. 1
Clinical Significance
Patients meeting ATP III criteria for metabolic syndrome face:
- 2-fold increased risk of developing cardiovascular disease over 5-10 years 1
- 5-fold increased risk for type 2 diabetes mellitus 1
Important Caveats
Sensitivity limitations: The ATP III criteria have relatively low sensitivity (39-46%) for identifying insulin-resistant individuals, though specificity is high (93-95%). 2, 3, 4 This means many insulin-resistant patients will not meet the full diagnostic criteria, yet those who do meet criteria are very likely to be insulin resistant.
Ethnic considerations: The waist circumference thresholds were developed primarily for Caucasian populations and may need adjustment for other ethnic groups. 1 The IDF later recommended lower thresholds (94 cm for men, 80 cm for women of European origin) to improve sensitivity. 1
Component utility varies: Among the five components, obesity and lipid criteria (triglycerides and HDL cholesterol) are most useful for identifying insulin resistance and making the diagnosis. 2